Top Biotechnology Stocks Gainers are NASDAQ: GNVC, LIFE, ONCY

GenVec, Inc. (NASDAQ:GNVC) is up 4.95% to $1.91 on 5.02 million shares. The stock hit an intraday high and an intraday low of $1.98 and $1.75 respectively. In the last six months the stock went up over 112%. GenVec, Inc. is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/.

Life Technologies Corp. (NASDAQ:LIFE) soars 4.82% to $51.03 on 1.79 million shares after the company announced that for fiscal 2010, it expects organic revenues to increase in the mid to high single digits. This level of organic revenue growth is expected to result in approximately $3.30 to $3.50 of non-GAAP earnings per share. The Company reported revenue of $3.30 billion in fiscal 2009. According to Reuters Estimates, analysts were expecting the Company to report EPS of $3.34 for the same period.

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) surges 7.14% to $2.25. The stock hit an intraday high and an intraday low of $2.25 and $2.05 respectively. In the last six months the stock went up over 18%. Oncolytics Biotech Inc. is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics.

About http://www.PennyStockPickReport.com

Penny Stock Pick Report offers a stock newsletter on OTC, PINKSHEETS ,OTCBB, and AMEX Stocks. Our subscribers receive daily up to date stock information on midcap, smallcap penny stocks and also stocks that are traded at NASDAQ and NYSE stock exchange. If you wish to feature your organization on our website then you can contact us at the email given below.